Please enable JavaScript to continue using this application.

Compare $ACRV vs $HRTX | Chartloom

Compare

$ACRV vs $HRTX

Acrivon Therapeutics Inc · Heron Therapeutics Inc

ACRV

Acrivon Therapeutics Inc

HRTX

Heron Therapeutics Inc

Compare $ACRV vs $HRTX

Comparing Acrivon Therapeutics Inc and Heron Therapeutics Inc

ACRVAcrivon Therapeutics Inc

HRTXHeron Therapeutics Inc

ACRVAcrivon Therapeutics Inc

Market cap

$82M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-22.4%

52W performance

1.6%

FCF yield

-78.5%

HRTXHeron Therapeutics Inc

Market cap

$77M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

1.0%

YTD performance

-67.8%

52W performance

-69.9%

FCF yield

-15.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ACRV

HRTX

Detailed metrics comparison

ACRV

Acrivon Therapeutics Inc

HRTX

Heron Therapeutics Inc

Market Cap

ACRV$82M

HRTX$77M

Enterprise Value

ACRV$40M

HRTX$199M

Price

ACRV$1.91

HRTX$0.41

P/E Ratio

ACRVN/A

HRTXN/A

P/S Ratio

ACRV0.00x

HRTX0.51x

EV/Sales

ACRV0.00x

HRTX1.31x

EV/EBITDA

ACRV0.00x

HRTX79.76x

P/B Ratio

ACRV0.98x

HRTX9.55x

P/FCF Ratio

ACRVN/A

HRTXN/A

EV/FCF

ACRV-0.63x

HRTX-16.38x

PEG Ratio

ACRVN/A

HRTXN/A

Forward P/E (NTM)

ACRVN/A

HRTXN/A

Forward P/S (NTM)

ACRVN/A

HRTXN/A

Revenue (TTM)

ACRV$0

HRTX$151M

Revenue Growth (YoY)

ACRVN/A

HRTX1.0%

Forward Rev Growth

ACRV406.9%

HRTX-1.6%

Gross Margin (TTM)

ACRV0.0%

HRTX70.1%

Operating Margin (TTM)

ACRV0.0%

HRTX0.0%

EBITDA Margin (TTM)

ACRV0.0%

HRTX-5.8%

Net Margin (TTM)

ACRV0.0%

HRTX-22.5%

FCF Margin (TTM)

ACRVN/A

HRTX-8.0%

Net Income (TTM)

ACRV$-74M

HRTX$-34M

FCF (TTM)

ACRV$-64M

HRTX$-12M

EPS (TTM)

ACRV-$1.77

HRTX-$0.18

ROE (TTM)

ACRV-7014.0%

HRTX-30090.0%

ROA (TTM)

ACRV-6161.0%

HRTX-1357.0%

ROIC (TTM)

ACRV-7014.0%

HRTX-2233.0%

Cash

ACRV$41M

HRTX$21M

Debt

ACRV$0

HRTX$143M

Net Cash/Debt

ACRV$41M

HRTX$-122M

Current Ratio (TTM)

ACRV7.99x

HRTX2.49x

Quick Ratio (TTM)

ACRV7.86x

HRTX1.44x

Debt/Equity (TTM)

ACRV0.00x

HRTX20.65x

Debt/Assets (TTM)

ACRV0.0%

HRTX0.0%

Interest Coverage (TTM)

ACRVN/A

HRTXN/A

Net Debt/EBITDA (TTM)

ACRV0.00x

HRTX0.00x

Beta

ACRV1.95

HRTX1.65

52W Performance

ACRV1.6%

HRTX-69.9%

YTD Performance

ACRV-22.4%

HRTX-67.8%

% from 52W High

ACRV-46.3%

HRTX-74.3%

% from 52W Low

ACRV50.4%

HRTX55.6%

Asset Turnover (TTM)

ACRV0.00x

HRTX0.60x

FCF Yield (TTM)

ACRV-78.5%

HRTX-15.8%

Earnings Yield (TTM)

ACRV-90.8%

HRTX-44.3%

Dividend Yield (TTM)

ACRVN/A

HRTXN/A

Rule of 40

ACRV0.0

HRTX-7.0

EV/GP/RG

ACRVN/A

HRTXN/A

Ticker research

View ACRV research View HRTX research

Metric	ACRV Acrivon Therapeutics Inc	HRTX Heron Therapeutics Inc
Market & Valuation
Market Cap	$82M	$77M
Enterprise Value	$40M	$199M
Price	$1.91	$0.41
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.51x
EV/Sales	0.00x	1.31x
EV/EBITDA	0.00x	79.76x
P/B Ratio	0.98x	9.55x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.63x	-16.38x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$151M
Revenue Growth (YoY)	N/A	1.0%
Forward Rev Growth	406.9%	-1.6%
Profitability
Gross Margin (TTM)	0.0%	70.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-5.8%
Net Margin (TTM)	0.0%	-22.5%
FCF Margin (TTM)	N/A	-8.0%
Net Income (TTM)	$-74M	$-34M
FCF (TTM)	$-64M	$-12M
EPS (TTM)	-$1.77	-$0.18
ROE (TTM)	-7014.0%	-30090.0%
ROA (TTM)	-6161.0%	-1357.0%
ROIC (TTM)	-7014.0%	-2233.0%
Financial Health
Cash	$41M	$21M
Debt	$0	$143M
Net Cash/Debt	$41M	$-122M
Current Ratio (TTM)	7.99x	2.49x
Quick Ratio (TTM)	7.86x	1.44x
Debt/Equity (TTM)	0.00x	20.65x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.95	1.65
52W Performance	1.6%	-69.9%
YTD Performance	-22.4%	-67.8%
% from 52W High	-46.3%	-74.3%
% from 52W Low	50.4%	55.6%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.60x
FCF Yield (TTM)	-78.5%	-15.8%
Earnings Yield (TTM)	-90.8%	-44.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-7.0
EV/GP/RG	N/A	N/A
Ticker research	View ACRV research	View HRTX research

Valuation

P/S Ratio

ACRV

0.00x

HRTX

0.51x

EV/FCF

HRTX

-16.38x

ACRV

-0.63x

Growth & revenue

Revenue Growth TTM

HRTX

1.0%

Forward Revenue Growth

ACRV

406.9%

HRTX

-1.6%

Profitability & performance

Gross Margin

HRTX

70.1%

ACRV

0.0%

ROE

ACRV

-7014.0%

HRTX

-30090.0%

FCF Yield %

HRTX

-15.8%

ACRV

-78.5%

52-Week Performance

ACRV

1.6%

HRTX

-69.9%

Detailed metrics comparison

ACRV

Acrivon Therapeutics Inc

HRTX

Heron Therapeutics Inc

Market Cap

ACRV$82M

HRTX$77M

Enterprise Value

ACRV$40M

HRTX$199M

Price

ACRV$1.91

HRTX$0.41

P/E Ratio

ACRVN/A

HRTXN/A

P/S Ratio

ACRV0.00x

HRTX0.51x

EV/Sales

ACRV0.00x

HRTX1.31x

EV/EBITDA

ACRV0.00x

HRTX79.76x

P/B Ratio

ACRV0.98x

HRTX9.55x

P/FCF Ratio

ACRVN/A

HRTXN/A

EV/FCF

ACRV-0.63x

HRTX-16.38x

PEG Ratio

ACRVN/A

HRTXN/A

Forward P/E (NTM)

ACRVN/A

HRTXN/A

Forward P/S (NTM)

ACRVN/A

HRTXN/A

Revenue (TTM)

ACRV$0

HRTX$151M

Revenue Growth (YoY)

ACRVN/A

HRTX1.0%

Forward Rev Growth

ACRV406.9%

HRTX-1.6%

Gross Margin (TTM)

ACRV0.0%

HRTX70.1%

Operating Margin (TTM)

ACRV0.0%

HRTX0.0%

EBITDA Margin (TTM)

ACRV0.0%

HRTX-5.8%

Net Margin (TTM)

ACRV0.0%

HRTX-22.5%

FCF Margin (TTM)

ACRVN/A

HRTX-8.0%

Net Income (TTM)

ACRV$-74M

HRTX$-34M

FCF (TTM)

ACRV$-64M

HRTX$-12M

EPS (TTM)

ACRV-$1.77

HRTX-$0.18

ROE (TTM)

ACRV-7014.0%

HRTX-30090.0%

ROA (TTM)

ACRV-6161.0%

HRTX-1357.0%

ROIC (TTM)

ACRV-7014.0%

HRTX-2233.0%

Cash

ACRV$41M

HRTX$21M

Debt

ACRV$0

HRTX$143M

Net Cash/Debt

ACRV$41M

HRTX$-122M

Current Ratio (TTM)

ACRV7.99x

HRTX2.49x

Quick Ratio (TTM)

ACRV7.86x

HRTX1.44x

Debt/Equity (TTM)

ACRV0.00x

HRTX20.65x

Debt/Assets (TTM)

ACRV0.0%

HRTX0.0%

Interest Coverage (TTM)

ACRVN/A

HRTXN/A

Net Debt/EBITDA (TTM)

ACRV0.00x

HRTX0.00x

Beta

ACRV1.95

HRTX1.65

52W Performance

ACRV1.6%

HRTX-69.9%

YTD Performance

ACRV-22.4%

HRTX-67.8%

% from 52W High

ACRV-46.3%

HRTX-74.3%

% from 52W Low

ACRV50.4%

HRTX55.6%

Asset Turnover (TTM)

ACRV0.00x

HRTX0.60x

FCF Yield (TTM)

ACRV-78.5%

HRTX-15.8%

Earnings Yield (TTM)

ACRV-90.8%

HRTX-44.3%

Dividend Yield (TTM)

ACRVN/A

HRTXN/A

Rule of 40

ACRV0.0

HRTX-7.0

EV/GP/RG

ACRVN/A

HRTXN/A

Ticker research

View ACRV research View HRTX research

Metric	ACRV Acrivon Therapeutics Inc	HRTX Heron Therapeutics Inc
Market & Valuation
Market Cap	$82M	$77M
Enterprise Value	$40M	$199M
Price	$1.91	$0.41
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.51x
EV/Sales	0.00x	1.31x
EV/EBITDA	0.00x	79.76x
P/B Ratio	0.98x	9.55x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.63x	-16.38x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$151M
Revenue Growth (YoY)	N/A	1.0%
Forward Rev Growth	406.9%	-1.6%
Profitability
Gross Margin (TTM)	0.0%	70.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-5.8%
Net Margin (TTM)	0.0%	-22.5%
FCF Margin (TTM)	N/A	-8.0%
Net Income (TTM)	$-74M	$-34M
FCF (TTM)	$-64M	$-12M
EPS (TTM)	-$1.77	-$0.18
ROE (TTM)	-7014.0%	-30090.0%
ROA (TTM)	-6161.0%	-1357.0%
ROIC (TTM)	-7014.0%	-2233.0%
Financial Health
Cash	$41M	$21M
Debt	$0	$143M
Net Cash/Debt	$41M	$-122M
Current Ratio (TTM)	7.99x	2.49x
Quick Ratio (TTM)	7.86x	1.44x
Debt/Equity (TTM)	0.00x	20.65x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.95	1.65
52W Performance	1.6%	-69.9%
YTD Performance	-22.4%	-67.8%
% from 52W High	-46.3%	-74.3%
% from 52W Low	50.4%	55.6%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.60x
FCF Yield (TTM)	-78.5%	-15.8%
Earnings Yield (TTM)	-90.8%	-44.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-7.0
EV/GP/RG	N/A	N/A
Ticker research	View ACRV research	View HRTX research